Expression of transforming growth factor-β (TGFβ) and the TGFβ signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: Role in cartilage degradation, chondrogenesis and osteophyte formation

Annals of the Rheumatic Diseases

Volumn 65, Issue 11, 2006, Pages 1414-1421

  Blaney Davidson, E N ^a   Vitters, E L ^a   Van Der Kraan, P M ^a   Van Den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CHONDROGENESIS; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE; KNEE INSTABILITY; KNEE OSTEOARTHRITIS; MALE; MOUSE; NONHUMAN; OSTEOPHYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CHONDROGENESIS; DISEASE PROGRESSION; JOINT INSTABILITY; MALE; MICE; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 33748659352     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.045971     Document Type: Article

References (36)

1. Stoop R, van der Kraan PM, Buma P, Hollander AP, Poole AR, van den Berg WB. Denaturation of type II collagen in articular cartilage in experimental murine arthritis. Evidence for collagen degradation in both reversible and irreversible cartilage damage. J Pathol 1999;188:329-37.
2. Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 1990;171:231-47.
3. Bakker AC, van de Loo FAJ, van Beuningen HM, Sime P, van Lent PLEM, van der Kraan PM, et al. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 2002;9:128-36.
4. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002;169:507-14.
5. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994;71:279-90.
6. van den Berg WB, van Osch GJ, van der Kraan PM, van Beuningen HM. Cartilage destruction and osteophytes in instability-induced murine osteoarthritis: role of TGF beta in osteophyte formation? Agents Actions 1993;40:215-19.
7. Morales TI, Joyce ME, Sobel ME, Danielpour D, Roberts AB. Transforming growth factor-beta in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys 1991;288:397-405.
8. Morales TI. Transforming growth factor-beta 1 stimulates synthesis of proteoglycan aggregates in calf articular cartilage organ cultures. Arch Biochem Biophys 1991;286:99-106.
9. Redini F, Galera P, Mauviel A, Loyau G, Pujol JP. Transforming growth factor beta stimulates collagen and glycosaminoglycan biosynthesis in cultured rabbit articular chondrocytes. FEBS Lett 1988;234:172-6.
10. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Does TGF-beta protect articular cartilage in vivo? Agents Actions Suppl 1993;39:127-31.
11. van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Osteoarthritis-like changes in the murine knee joint resulting from intraarticular transforming growth factor-beta injections. Osteoarthritis Cartilage 2000;8:25-33.
12. Hayami T, Pickarski M, Wesolowski GA, McLane J, Bone A, Destefano J, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention or osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004;50:1193-206.
13. Uchino M, Izumi T, Tominaga T, Wakita R, Minehara H, Sekiguchi M, et al. Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin Orthop 2000;377:119-25.
14. van der Kraan PM, Vitters EL, van Beuningen HM, van de Putte LB, van den Berg WB. Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol (Oxford) 1990;71:19-31.
15. Das Gupta EP, Lyons TJ, Hoyland JA, Lawton DM, Freemont AJ. New histological observations in spontaneously developing osteoarthritis in the STR/ORT mouse questioning its acceptability as a model of human osteoarthritis. Int J Exp Pathol 1993;74:627-34.
16. Mason RM, Chambers MG, Flannelly J, Gaffen JD, Dudhia J, Bayliss MT. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis Cartilage 2001;9:85-91.
17. Flannelly J, Chambers MG, Dudhia J, Hembry RM, Murphy G, Mason RM, et al. Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. Osteoarthritis Cartilage 2002;10:722-33.
18. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002;13:1464-72.
19. Nakao A, Imamura T, Souchelnitskiy S, Kawabata M, Ishisaki A, Oeda E, et al. TGF beta receptor mediated signalling through Smad2, Smad3 and Smad4. EMBO J 1997;16:5353-62.
20. Dunham J, Chambers MG, Jasani MK, Bitensky L, Chayen J. Changes in oxidative activities of chondrocytes during the early development of natural murine osteoarthritis. Br J Exp Pathol 1988;69:845-53.
21. Dunham J, Chambers MG, Jasani MK, Bitensky L, Chayen J. Changes in the orientation of proteoglycans during the early development of natural murine osteoarthritis. J Orthop Res 1990;8:101-4.
22. Verdier MP, Seite S, Guntzer K, Pujol JP, Boumediene K. Immunohistochemical analysis of transforming growth factor beta isoforms and their receptors in human cartilage from normal and osteoarthritic femoral heads. Rheumatol Int 2005;25:118-24.
23. Wang L, Almaqist KF, Veys EM, Verbruggen G. Control of extracellular matrix homeostasis or normal cartilage by a TGF beta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro. Osteoarthritis Cartilage 2002;10:188-98.
24. Kizawa H, Kou I, Iida A, Sudo A, Miyamoto Y, Fukuda A, et al. An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis. Nat Genet 2005;37:138-44.
25. Scharstuhl A, Vitters EL, van der Kraan PM, van den Berg WB. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003;48:3442-51.
26. van Osch GJ, van der Kraan PM, van den Berg WB. Site-specific cartilage changes in murine degenerative knee joint disease induced by iodoacetate and collagenase. J Orthop Res 1994;12:168-75.
27. Yang F, Shi Z. A study on papain-induced osteoarthritis in rabbit temporomandibular joint. Hua Xi Kou Qiang Yi Xue Za Zhi 2002;20:330-2.
28. Moriizumi T, Yamashita N, Okada Y. Papain-induced changes in the guinea pig knee joint with special reference to cartilage healing. Virchows Arch B Cell Pathol Ind Mol Pathol 1986;51:461-74.
29. van der Kraan PM, Vitters EL, van de Putte LB, van den Berg WB. Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol 1989;135:1001-14.
30. Zoricic S, Maric I, Bobinac D, Vukicevic S. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat 2003;202(Pt 3):269-77.
31. Nakase T, Miyaji T, Tomita T, Kaneko M, Kuriyama K, Myoui A, et al. Localization or bone morphogenetic protein-2 in human osteoarthritic cartilage and osteophyte. Osteoarthritis Cartilage 2003;11:278-84.
32. Collins C, Evans RG, Ponsford F, Miller P, Elson CJ. Chondro-osseous metaplasia, bone density and patellar cartilage proteoglycan content in the osteoarthritis of STR/ORT mice. Osteoarthritis Cartilage 1994;2:111-8.
33. Walton M. Degenerative joint disease in the mouse knee; radiological and morphological observations. J Pathol 1977;123:97-107.
34. Boumediene K, Conrozier T, Mathieu P, Richard M, Marcelli C, Vignon E, et al. Decrease of cartilage transforming growth factor-beta receptor II expression in the rabbit experimental steoarthritis-potential role in cartilage breakdown. Osteoarthritis Cartilage 1998;6:146-9.
35. Studer RK, Georgescu HI, Miller LA, Evans CH. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 1999;42:248-57.
36. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell U. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 2003;85-A(Suppl 3):59-66.